Chilblain-like lesions with prominent bullae in a patient with COVID-19. Rubin, A., Alamgir, M., Rubin, J., & Rao, B. K. BMJ case reports, 13(11):e237917, November, 2020. ![Chilblain-like lesions with prominent bullae in a patient with COVID-19 [link]](https://bibbase.org/img/filetypes/link.svg "link")
Paper doi abstract bibtex A 27-year-old patient presented with acral chilblain-like lesions atypical of dermatological presentations appearing in current reports of COVID-19. Prominent bullae had formed on the dorsa of her toes and became haemorrhagic 2 days after the initial presentation. The patient had no underlying medical conditions, including any history of collagen vascular disease, Raynaud's phenomenon, chilblains or cold exposure, and was not taking any medications. The patient reported 10 days of ageusia and anosmia 6 weeks prior to the manifestation of her toe lesions, with no other symptoms. A nasopharyngeal swab test for SARS-CoV-2 RNA was positive. It is important that physicians recognise the myriad of cutaneous lesions associated with COVID-19 in this ongoing pandemic.
@article{rubin_chilblain-like_2020,
title = {Chilblain-like lesions with prominent bullae in a patient with {COVID}-19},
volume = {13},
copyright = {All rights reserved},
issn = {1757-790X},
url = {http://www.ncbi.nlm.nih.gov/pubmed/33139373},
doi = {10.1136/bcr-2020-237917},
abstract = {A 27-year-old patient presented with acral chilblain-like lesions atypical of dermatological presentations appearing in current reports of COVID-19. Prominent bullae had formed on the dorsa of her toes and became haemorrhagic 2 days after the initial presentation. The patient had no underlying medical conditions, including any history of collagen vascular disease, Raynaud's phenomenon, chilblains or cold exposure, and was not taking any medications. The patient reported 10 days of ageusia and anosmia 6 weeks prior to the manifestation of her toe lesions, with no other symptoms. A nasopharyngeal swab test for SARS-CoV-2 RNA was positive. It is important that physicians recognise the myriad of cutaneous lesions associated with COVID-19 in this ongoing pandemic.},
language = {eng},
number = {11},
journal = {BMJ case reports},
author = {Rubin, Alexandra and Alamgir, Mahin and Rubin, Julia and Rao, Babar K.},
month = nov,
year = {2020},
pages = {e237917},
}
Downloads: 0
{"_id":"N6kkj6JMAT3HCbneD","bibbaseid":"rubin-alamgir-rubin-rao-chilblainlikelesionswithprominentbullaeinapatientwithcovid19-2020","author_short":["Rubin, A.","Alamgir, M.","Rubin, J.","Rao, B. K."],"bibdata":{"bibtype":"article","type":"article","title":"Chilblain-like lesions with prominent bullae in a patient with COVID-19","volume":"13","copyright":"All rights reserved","issn":"1757-790X","url":"http://www.ncbi.nlm.nih.gov/pubmed/33139373","doi":"10.1136/bcr-2020-237917","abstract":"A 27-year-old patient presented with acral chilblain-like lesions atypical of dermatological presentations appearing in current reports of COVID-19. Prominent bullae had formed on the dorsa of her toes and became haemorrhagic 2 days after the initial presentation. The patient had no underlying medical conditions, including any history of collagen vascular disease, Raynaud's phenomenon, chilblains or cold exposure, and was not taking any medications. The patient reported 10 days of ageusia and anosmia 6 weeks prior to the manifestation of her toe lesions, with no other symptoms. A nasopharyngeal swab test for SARS-CoV-2 RNA was positive. It is important that physicians recognise the myriad of cutaneous lesions associated with COVID-19 in this ongoing pandemic.","language":"eng","number":"11","journal":"BMJ case reports","author":[{"propositions":[],"lastnames":["Rubin"],"firstnames":["Alexandra"],"suffixes":[]},{"propositions":[],"lastnames":["Alamgir"],"firstnames":["Mahin"],"suffixes":[]},{"propositions":[],"lastnames":["Rubin"],"firstnames":["Julia"],"suffixes":[]},{"propositions":[],"lastnames":["Rao"],"firstnames":["Babar","K."],"suffixes":[]}],"month":"November","year":"2020","pages":"e237917","bibtex":"@article{rubin_chilblain-like_2020,\n\ttitle = {Chilblain-like lesions with prominent bullae in a patient with {COVID}-19},\n\tvolume = {13},\n\tcopyright = {All rights reserved},\n\tissn = {1757-790X},\n\turl = {http://www.ncbi.nlm.nih.gov/pubmed/33139373},\n\tdoi = {10.1136/bcr-2020-237917},\n\tabstract = {A 27-year-old patient presented with acral chilblain-like lesions atypical of dermatological presentations appearing in current reports of COVID-19. Prominent bullae had formed on the dorsa of her toes and became haemorrhagic 2 days after the initial presentation. The patient had no underlying medical conditions, including any history of collagen vascular disease, Raynaud's phenomenon, chilblains or cold exposure, and was not taking any medications. The patient reported 10 days of ageusia and anosmia 6 weeks prior to the manifestation of her toe lesions, with no other symptoms. A nasopharyngeal swab test for SARS-CoV-2 RNA was positive. It is important that physicians recognise the myriad of cutaneous lesions associated with COVID-19 in this ongoing pandemic.},\n\tlanguage = {eng},\n\tnumber = {11},\n\tjournal = {BMJ case reports},\n\tauthor = {Rubin, Alexandra and Alamgir, Mahin and Rubin, Julia and Rao, Babar K.},\n\tmonth = nov,\n\tyear = {2020},\n\tpages = {e237917},\n}\n\n","author_short":["Rubin, A.","Alamgir, M.","Rubin, J.","Rao, B. K."],"key":"rubin_chilblain-like_2020","id":"rubin_chilblain-like_2020","bibbaseid":"rubin-alamgir-rubin-rao-chilblainlikelesionswithprominentbullaeinapatientwithcovid19-2020","role":"author","urls":{"Paper":"http://www.ncbi.nlm.nih.gov/pubmed/33139373"},"metadata":{"authorlinks":{}},"html":""},"bibtype":"article","biburl":"https://bibbase.org/zotero-mypublications/raoresearch","dataSources":["aGgndugSyribdb2rd","2tgmyzKov4y6MHvQs"],"keywords":[],"search_terms":["chilblain","lesions","prominent","bullae","patient","covid","rubin","alamgir","rubin","rao"],"title":"Chilblain-like lesions with prominent bullae in a patient with COVID-19","year":2020}